Reported relationships
Latest disclosed role at each company.
No relationships currently tracked through insider filings.
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
No balances currently tracked through insider filings.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
CONMED Corp
Report date June 01, 2018 · Filed June 01, 2018
Section 16 reporting ended · disclosed 2018-06-01. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 9,949 |
Reported balance
After 2018-06-01 transaction · row 1
1 source rowRow 1 · 2018-06-01 · Exercise / conversion · Acquired 2,167 · Balance 9,949 |
| Rsus (restricted Stock Units)SEC Table II · derivative / convertible security · Conversion / exercise price $0.00 · Expires 2027-06-01 | Direct | 0 |
Reported balance
After 2018-06-01 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2018-06-01 · Exercise / conversion · Disposed 2,167 · Balance 0 F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2016 Amended and Restated Non-Employee Director Equity Compensation Plan, with the RSUs generally vesting 100% after a one year period. |
Filing footnotes · ownership attribution and instrument terms
F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2016 Amended and Restated Non-Employee Director Equity Compensation Plan, with the RSUs generally vesting 100% after a one year period.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 01, 2018 Filed Jun 1, 2018 20:19 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionRsus (restricted Stock Units) · Derivative | 2,167 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-019519 · form4.xml · derivative · entry 2 GOLDEN JO ANN · CIK 0001238330 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,167 shares Expires 2027-06-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2016 Amended and Restated Non-Employee Director Equity Compensation Plan, with the RSUs generally vesting 100% after a one year period. Read SEC document |
| June 01, 2018 Filed Jun 1, 2018 20:19 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionCommon Stock | 2,167 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-019519 · form4.xml · nonDerivative · entry 1 GOLDEN JO ANN · CIK 0001238330 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,949 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 10, 2018 Filed May 11, 2018 14:45 UTC | CONMED Corp CNMD · Entity 4691 | SaleCommon Stock | 3,000 | $67.62 | $202,857.00 |
DisclosureSEC source: 0001127602-18-017141 · form4.xml · nonDerivative · entry 1 GOLDEN JO ANN · CIK 0001238330 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,782 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $67.61 to $67.65. Full information regarding the number of shares sold at each separate price will be provided upon request of the commission staff, ConMed, or a ConMed security holder. Read SEC document |
| May 07, 2018 Filed May 8, 2018 15:05 UTC | CONMED Corp CNMD · Entity 4691 | SaleCommon Stock | 3,000 | $67.23 | $201,690.00 |
DisclosureSEC source: 0001127602-18-016568 · form4.xml · nonDerivative · entry 1 GOLDEN JO ANN · CIK 0001238330 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,782 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $67.22 to $67.27. Full information regarding the number of shares sold at each separate price will be provided upon request of the commission staff, ConMed, or a ConMed security holder. Read SEC document |
| April 27, 2018 Filed Apr 30, 2018 19:15 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionOptions To Purchase Common Stock · Derivative | 2,698 | $0.00 Strike: $41.06 | $0.00 |
DisclosureSEC source: 0001127602-18-015508 · form4.xml · derivative · entry 3 GOLDEN JO ANN · CIK 0001238330 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,698 Underlying: Common Stock · 2,698 shares Expires 2026-06-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The incentive stock options ("ISOs") were granted under the Company's 2016 Amended and Restated Non-Employee Director Equity Compensation Plan and generally vest 100% after a one year period. Read SEC document |
| April 27, 2018 Filed Apr 30, 2018 19:15 UTC | CONMED Corp CNMD · Entity 4691 | SaleCommon Stock | 5,698 | $65.40 | $372,649.20 |
DisclosureSEC source: 0001127602-18-015508 · form4.xml · nonDerivative · entry 2 GOLDEN JO ANN · CIK 0001238330 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,782 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $65.19 to $65.53. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. Read SEC document |
| April 27, 2018 Filed Apr 30, 2018 19:15 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionCommon Stock | 2,698 | $41.06 | $110,779.88 |
DisclosureSEC source: 0001127602-18-015508 · form4.xml · nonDerivative · entry 1 GOLDEN JO ANN · CIK 0001238330 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,480 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 01, 2018 Filed Feb 2, 2018 20:42 UTC | CONMED Corp CNMD · Entity 4691 | SaleCommon Stock | 3,000 | $63.90 | $191,694.00 |
DisclosureSEC source: 0001127602-18-003616 · form4.xml · nonDerivative · entry 1 GOLDEN JO ANN · CIK 0001238330 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,782 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $63.88 to $63.94. Full information regarding the number of shares sold at each price will be provided upon request of the commission staff, ConMed, or a ConMed security holder. Read SEC document |
| August 14, 2017 Filed Aug 15, 2017 20:04 UTC | CONMED Corp CNMD · Entity 4691 | SaleCommon Stock | 3,000 | $50.00 | $150,000.00 |
DisclosureSEC source: 0001127602-17-025637 · form4.xml · nonDerivative · entry 1 GOLDEN JO ANN · CIK 0001238330 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,782 Read SEC document |
| June 01, 2017 Filed Jun 2, 2017 19:43 UTC | CONMED Corp CNMD · Entity 4691 | GrantOptions To Purchase Common Stock · Derivative | 3,669 | $51.90 Strike: $51.90 | $190,421.10 |
DisclosureSEC source: 0001127602-17-020269 · form4.xml · derivative · entry 4 GOLDEN JO ANN · CIK 0001238330 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,669 Underlying: Common Stock · 3,669 shares Expires 2027-06-01 F2 · derivative.exercise_date: The incentive stock options ("ISOs") were granted under the Company's 2016 Amended and Restated Non-Employee Director Equity Compensation Plan and generally vest 100% after a one year period. Read SEC document |
| June 01, 2017 Filed Jun 2, 2017 19:43 UTC | CONMED Corp CNMD · Entity 4691 | GrantRsus (restricted Stock Units) · Derivative | 2,167 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-020269 · form4.xml · derivative · entry 3 GOLDEN JO ANN · CIK 0001238330 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,167 Underlying: Common Stock · 2,167 shares Expires 2027-06-01 F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2016 Amended and Restated Non-Employee Director Equity Compensation Plan, with the RSUs generally vesting 100% after a one year period. Read SEC document |
| June 01, 2017 Filed Jun 2, 2017 19:43 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionRsus (restricted Stock Units) · Derivative | 2,739 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-020269 · form4.xml · derivative · entry 2 GOLDEN JO ANN · CIK 0001238330 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,739 shares Expires 2026-06-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2016 Amended and Restated Non-Employee Director Equity Compensation Plan, with the RSUs generally vesting 100% after a one year period. Read SEC document |
| June 01, 2017 Filed Jun 2, 2017 19:43 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionCommon Stock | 2,739 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-020269 · form4.xml · nonDerivative · entry 1 GOLDEN JO ANN · CIK 0001238330 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,782 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.